Physician profile
Anthony W Roccisano
NPI 1730371030
$79,588.18
in general payments reported to CMS, 2019-2025
13 companies · $11K in 2025
The $11K reported for 2025 was more than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $1,300 · 2021: $2,374 · 2022: $13K · 2023: $17K · 2024: $23K · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $34K · Consulting Fee: $7,350 · Travel and Lodging: $6,287 · Food and Beverage: $2,591.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $34,350.00 |
| Consulting Fee | $7,350.00 |
| Travel and Lodging | $6,287.13 |
| Food and Beverage | $2,590.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $64,280.61 | 2021-2025 | Anteralign Spinal System With Titan Nanolock Surface Technology, Clydesdale Ptc Spinal System, Catalyft Pl Expandable Interbody System |
| Medtronic USA, INC. | $9,936.19 | 2019-2020 | |
| Centinel Spine, LLC | $2,500.00 | 2019 | |
| Sioux Surgical INC | $814.58 | 2024 | |
| Nuvasive, INC. | $793.58 | 2019-2020 | |
| Arthrex, INC. | $302.65 | 2024 | |
| Next Science LLC | $287.28 | 2024-2025 | Blastx, Xperience, Surgx |
| Aesculap Implant Systems, LLC | $149.94 | 2019-2021 | |
| Baxter Healthcare | $126.75 | 2019-2021 | |
| Depuy Synthes Sales INC. | $125.56 | 2019-2022 | |
| Nevro Corp. | $94.44 | 2019 | |
| Augmedics INC. | $92.50 | 2021 | |
| Brainlab, INC. | $84.10 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Roccisano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.